Potassium Ion

Potassium Ion

SCHEMBL2139388

CCCCCCCCCCC=CC(CC(=O)[O-])C(=O)[O-].[K+].[K+]

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
FABP3 P05413 7/20 0.56
SLC6A5 Q9Y345 1/20 0.45
EPHX2 P34913 1/20 0.44
FAAH O00519 1/20 0.42
MEN1 O00255 1/20 0.42
CYP3A4 P08684 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium Ion SCHEMBL8669137 1.00 FABP3 (0.56) FABP3SLC6A5EPHX2FAAHMEN1
Potassium Ion SCHEMBL5597233 1.00 FABP3 (0.56) FABP3SLC6A5EPHX2FAAHMEN1
Potassium Ion SCHEMBL5597298 1.00 FABP3 (0.56) FABP3SLC6A5EPHX2FAAHMEN1
Potassium Ion SCHEMBL1534741 1.00 FABP3 (0.56) FABP3SLC6A5EPHX2FAAHMEN1
Potassium Ion SCHEMBL5597299 1.00 FABP3 (0.56) FABP3SLC6A5EPHX2FAAHMEN1
Potassium Ion SCHEMBL5690557 1.00 FABP3 (0.56) FABP3SLC6A5EPHX2FAAHMEN1
Potassium Ion SCHEMBL1534743 1.00 FABP3 (0.56) FABP3SLC6A5EPHX2FAAHMEN1
Potassium Ion SCHEMBL8669136 1.00 FABP3 (0.56) FABP3SLC6A5EPHX2FAAHMEN1
Potassium Ion SCHEMBL5690504 1.00 FABP3 (0.56) FABP3SLC6A5EPHX2FAAHMEN1
Potassium Ion SCHEMBL5597232 1.00 FABP3 (0.56) FABP3SLC6A5EPHX2FAAHMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109295802-B Preparation method of high-surface-strength color ink-jet printing paper 安徽文峰特种纸业有限公司 2021-04-06 CN claimed
US-20090257968-A1 Gels containing anionic surfactants and coupling agents WALTON RICHARD 2009-10-15 US claimed
US-20050220832-A1 Gels containing metallic soaps and coupling agents WALTON RICHARD 2005-10-06 US claimed
WO-2023243681-A1 SYNTHETIC FIBER TREATMENT AGENT AND SYNTHETIC FIBER 竹本油脂株式会社 2023-12-21 WO disclosed
CN-109295802-B Preparation method of high-surface-strength color ink-jet printing paper 安徽文峰特种纸业有限公司 2021-04-06 CN disclosed
CN-109295802-B Preparation method of high-surface-strength color ink-jet printing paper 安徽文峰特种纸业有限公司 2021-04-06 CN disclosed
CN-109082028-B Preparation method of PVC (polyvinyl chloride) coiled material for wrapping metal 阜南县富昌恒业工艺品有限公司 2020-12-11 CN disclosed
CN-109082028-B Preparation method of PVC (polyvinyl chloride) coiled material for wrapping metal 阜南县富昌恒业工艺品有限公司 2020-12-11 CN disclosed
US-10753038-B2 Oil solution for carbon fiber precursors and carbon fiber precursor TAKEMOTO YUSHI KABUSHIKI KAISHA (JP) 2020-08-25 US disclosed
CN-108395943-B Multifunctional efficient water-based cleaning agent and preparation method thereof 上海巨石化工有限公司 2020-04-03 CN disclosed
US-20190234014-A1 OIL SOLUTION FOR CARBON FIBER PRECURSORS AND CARBON FIBER PRECURSOR TAKEMOTO YUSHI KABUSHIKI KAISHA (JP) 2019-08-01 US disclosed
US-20030079297-A1 Agents and methods for treating biodegradable synthetic yarns TAKEMOTO YUSHI KABUSHIKI KAISHA 2003-05-01 US disclosed
US-6296933-B1 FOR USE AS MAKEUP PUFFS, WET TISSUES OR DRAINING BAGS, MEDICAL USES SUCH AS BASE FABRICS FOR FOMENTATIONS, AGRICULTURAL AND CIVIL ENGINEERING USES SUCH AS HYDROPONIC MATS OR DRAINING MATS, CLOTHING SUCH AS UNDERWEAR TEIJIN LIMITED (JP) 2001-10-02 US disclosed
EP-1083258-A1 HYDROPHILIC FIBER TEIJIN LIMITED (JP) 2001-03-14 EP disclosed
EP-0957127-A1 Acrylic elastomer composition NIPPON MEKTRON, LTD. (JP) 1999-11-17 EP disclosed
EP-0267653-B1 DETERGENT COMPOSITION CONTAINING ETHYLENEDIAMINE-N,N' DISUCCINIC ACID THE PROCTER & GAMBLE COMPANY (US) 1992-09-02 EP disclosed
US-4985177-A CONCENTRATED LIQUID DETERGENT CONTAINING A SULFATE OR SULFONATE ANIONIC SURFACTANT, A NONIONIC OR AMPHOTERIC SURFACTANT, A SUCCINIC ACID DERIVATIVE AND AN ALKYLBENZENESULFONATE KAO CORPORATION (JP) 1991-01-15 US disclosed
EP-0267653-A2 Detergent composition containing ethylenediamine-N,N' disuccinic acid THE PROCTER & GAMBLE COMPANY (US) 1988-05-18 EP disclosed
US-4704233-A BIODEGRADABLE CHELANT THE PROCTER & GAMBLE COMPANY (US) 1987-11-03 US disclosed
US-4698181-A PEROXIDE-FREE STAIN REMOVAL THE PROCTER & GAMBLE COMPANY (US) 1987-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050220832-A1 Gels containing metallic soaps and coupling agents MSN, S100P, STMN1 FABP3 4151/4885SLC6A5 1507/4885EPHX2 58/4885
US-20090257968-A1 Gels containing anionic surfactants and coupling agents RAB5IF, ANXA4, ANXA11 FABP3 2647/4885SLC6A5 993/4885EPHX2 117/4885
US-20190234014-A1 OIL SOLUTION FOR CARBON FIBER PRECURSORS AND CARBON FIBER PRECURSOR SGMS2, SGMS1, CNOT7 FABP3 1063/4885SLC6A5 2432/4885EPHX2 1961/4885
US-10753038-B2 Oil solution for carbon fiber precursors and carbon fiber precursor SGMS2, SGMS1, CNOT7 FABP3 1063/4885SLC6A5 2432/4885EPHX2 1961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.